| 1 |
中华医学会器官移植学分会. 辅助肝移植临床应用指南(2024版)[J]. 中华消化外科杂志，2024, 23(11): 1373-1388.
|
| 2 |
Dehghani SM, Haghighat M, Eghbali F, et al. Thyroid hormone levels in children with liver cirrhosis awaiting a liver transplant[J]. Exp Clin Transplant, 2013, 11(2):150-153.
|
| 3 |
Novitzky D, Mi Z, Videla LA, et al. Thyroid hormone therapy and procurement of livers from brain-dead donors[J]. Endocr Res, 2016, 41(3):270-273.
|
| 4 |
Suarez-Zdunek MA, Arentoft NS, Krohn PS, et al. Prevalence of hyperthyroidism and hypothyroidism in liver transplant recipients and associated risk factors[J]. Sci Rep, 2024, 14(1):7828.
|
| 5 |
Videla LA, Valenzuela R. Perspectives in liver redox imbalance: toxicological and pharmacological aspects underlying iron overloading, nonalcoholic fatty liver disease, and thyroid hormone action[J]. Biofactors, 2022, 48(2):400-415.
|
| 6 |
Silveira MG, Mendes FD, Diehl NN, et al. Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and nonalcoholic fatty liver disease[J]. Liver Int, 2009, 29(7):1094-1100.
|
| 7 |
Yen PM. Physiological and molecular basis of thyroid hormone action[J]. Physiol Rev, 2001, 81(3): 1097-1142.
|
| 8 |
Feng S, Roll GR, Rouhani FJ, et al. The future of liver transplantation[J]. Hepatology, 2024, 80(3):674-697.
|
| 9 |
张剑，陈煜，段钟平. 血清游离三甲碘状腺原氨酸水平预测HBV相关慢加急性肝衰竭患者预后的价值分析[J]. 临床肝胆病杂志，2022, 38(1):81-85.
|
| 10 |
王滢，向泽，童玲，等. 游离三碘甲状腺原氨酸在戊型肝炎相关急性肝衰竭患者预后评估价值研究[J]. 中华临床感染病杂志，2022, 15(5): 345-351.
|
| 11 |
Corinti D, Chiavarino B, Spano M, et al. Molecular basis for the remarkably different gas-phase behavior of deprotonated thyroid hormones triiodothyronine (T3) and reverse triiodothyronine (rT3): a clue for their discrimination？[J]. Anal Chem, 2021, 93(44):14869-14877.
|
| 12 |
Kelly GS. Peripheral metabolism of thyroid hormones: a review[J]. Altern Med Rev, 2000, 5(4):306-333.
|
| 13 |
雷联会，韦中余，程芮，等. 肝移植受者围手术期甲状腺激素水平对预后的影响[J]. 中华器官移植杂志，2008, 29(10):612-614.
|
| 14 |
Koshik A, Kurpiewska D, Janik M, et al. Thyroid hormone alterations in acute-on-chronic liver failure: a focus on liver transplantation and survival outcomes[J]. Pol Arch Intern Med, 2025, 134(4):16989.
|
| 15 |
Anastasiou O, Sydor S, Sowa JP, et al. Higher thyroid-stimulating hormone, triiodothyronine and thyroxine values are associated with better outcome in acute liver failure[J]. PLoS One, 2015, 10(7): e0132189.
|
| 16 |
Van Thiel DH, Udani M, Schade RR, et al. Prognostic value of thyroid hormone levels in patients evaluated for liver transplantation[J]. Hepatology, 1985, 5(5):862-866.
|
| 17 |
Moura Neto A, Bovi TG, Righetto CM, et al. Frequency of thyroid dysfunction in patients with diabetes mellitus before and after liver transplantation[J]. Transplant Proc, 2018, 50(3):788-791.
|
| 18 |
Van Thiel DH, Gavaler JS, Tarter R, et al. Pituitary and thyroid hormone levels before and after orthotopic hepatic transplantation and their responses to thyrotropin-releasing hormone[J]. J Clin Endocrinol Metab, 1985, 60(3):569-574.
|
| 19 |
Antoniou EA, Rizos D, Achilleos O, et al. Thyroid hormone in liver allograft rejection[J]. Transplant Proc, 1997, 29(1-2):503-504.
|
| 20 |
Huang G, Ueda M, Tasaki M, et al. Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation[J]. Amyloid, 2017, 24(1):24-29.
|
| 21 |
Kuiper GG, Kester MH, Peeters RP, et al. Biochemical mechanisms of thyroid hormone deiodination[J]. Thyroid, 2005, 15(8):787-798.
|
| 22 |
Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism[J]. Physiol Rev, 2014, 94(2): 355-382.
|
| 23 |
Schussler GC, Schaffner F, Korn F. Increased serum thyroid hormone binding and decreased free hormone in chronic active liver disease[J]. N Engl J Med, 1978, 299(10):510-515.
|
| 24 |
杨云，王晓东. 甲状腺激素与肠道功能关系的研究进展[J]. 南京医科大学学报(自然科学版), 2025,45(1):133-138.
|
| 25 |
Song Y, Xu C, Shao S, et al. Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis[J]. J Hepatol, 2015, 62(5):1171-1179.
|
| 26 |
Liao CJ, Huang PS, Chien HT, et al. Effects of thyroid hormones on lipid metabolism pathologies in non-alcoholic fatty liver disease[J]. Biomedicines, 2022, 10(6):1232.
|
| 27 |
Piantanida E, Ippolito S, Gallo D, et al. The interplay between thyroid and liver: implications for clinical practice[J]. J Endocrinol Invest, 2020, 43(7):885-899.
|
| 28 |
Sinha RA, Singh BK, Yen PM. Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism[J]. Trends Endocrinol Metab, 2014, 25(10):538-545.
|
| 29 |
Van Steenbergen W, Fevery J, De Vos R, et al. Thyroid hormones and the hepatic handling of bilirubin. I. Effects of hypothyroidism and hyperthyroidism on the hepatic transport of bilirubin mono- and diconjugates in the Wistar rat[J]. Hepatology, 1989, 9(2):314-321.
|
| 30 |
Malik R, Habib M, Tootle R, et al. Exogenous thyroid hormone induces liver enlargement, whilst maintaining regenerative potential-a study relevant to donor preconditioning[J]. Am J Transplant, 2005,5(8):1801-1807.
|
| 31 |
Perra A, Kowalik MA, Cabras L, et al. Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration[J]. Cell Prolif, 2020, 53(5): e12808.
|
| 32 |
Taki-Eldin A, Zhou L, Xie HY, et al. Tri-iodothyronine enhances liver regeneration after living donor liver transplantation in rats[J]. J Hepatobiliary Pancreat Sci, 2011, 18(6): 806-814.
|
| 33 |
Oren R, Dabeva MD, Karnezis AN, et al. Role of thyroid hormone in stimulating liver repopulation in the rat by transplanted hepatocytes[J]. Hepatology, 1999, 30(4):903-913.
|
| 34 |
Alvarado TF, Puliga E, Preziosi M, et al. Thyroid hormone receptor β agonist induces β-catenin-dependent hepatocyte proliferation in mice: implications in hepatic regeneration[J]. Gene Expr, 2016, 17 (1):19-34.
|
| 35 |
Baxter JD, Dillmann WH, West BL, et al. Selective modulation of thyroid hormone receptor action[J]. J Steroid Biochem Mol Biol, 2001, 76(1-5):31-42.
|
| 36 |
Webb P. Selective activators of thyroid hormone receptors[J]. Expert Opin Investig Drugs, 2004, 13(5): 489-500.
|
| 37 |
Imberti R, Vairetti M, Gualea MR, et al. The effects of thyroid hormone modulation on rat liver injury associated with ischemia-reperfusion and cold storage[J]. Anesth Analg, 1998,86(6):1187-1193.
|
| 38 |
张柏，王鹏志，朱理玮. 大鼠原位肝移植模型建立和受体甲状腺激素水平变化的研究[J]. 天津医科大学学报，2001, 7(3):372-375.
|
| 39 |
Mardones M, Valenzuela R, Romanque P, et al. Prevention of liver ischemia reperfusion injury by a combined thyroid hormone and fish oil protocol[J]. J Nutr Biochem, 2012, 23(9):1113-1120.
|
| 40 |
Fernández V, Tapia G, Videla LA. Recent advances in liver preconditioning: thyroid hormone, n-3 long-chain polyunsaturated fatty acids and iron[J]. World J Hepatol, 2012, 4(4):119-128.
|
| 41 |
Czyzyk JK, Jakóbisiak M. Influence of cyclosporine A on thyroid function in the experimental autoimmune thyroiditis (EAT) in mice[J]. Arch Immunol Ther Exp (Warsz), 1995, 43(1):55-59.
|
| 42 |
Iwasaki H. Onset of Graves′ disease during long-term immunosuppressive therapy in a patient with membranous nephropathy[J]. Endocrinol Diabetes Metab Case Rep, 2015, 2015: 150046.
|
| 43 |
Glick AB, Wodzinski A, Fu PF, et al. Impairment of regulatory T cell function in autoimmune thyroid disease[J]. Thyroid, 2013, 23(7):871-878.
|
| 44 |
杨汉文，王强，张朋朋，等. 肝移植围手术期甲状腺功能变化与影响的研究进展[J]．中国普通外科杂志，2024,33(1):108-113.
|
| 45 |
Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism[J]. Thyroid, 2014, 24(12):1670-1751.
|
| 46 |
陈文倩，张雷，张弋，等. 实体器官移植他克莫司个体化治疗专家共识[J]. 中国医院用药评价与分析，2021,21(12):1409-1424.
|
| 47 |
王天玉，刘伟杰，高先，等. 炎症因子与甲状腺疾病的因果关联：孟德尔随机化研究[J]. 现代医学，2025,53(2):203-210.
|